Sunday - February 22, 2026

Methods of Treating ATPase-mediated Diseases With a Nucleic Acid Encoding ATP1A3 and a Neuron-Specific Promoter

2026-01-27

ALEXANDRIA, Virginia, Jan. 27 -- DUKE UNIVERSITY, Durham, North Carolina has been assigned a patent (No. US 12533397 B2, initially filed June 23, 2023) developed by six inventors Mohamad Mikati, Durham, North Carolina; Arsen Hunanyan, Durham, North Carolina; Boris Kantor, Durham, North Carolina; Aravind Asokan, Durham, North Carolina; Ram Puranam, Durham, North Carolina; and Dwight Koeberl, Durham, North Carolina, for "Methods of treating ATPase-mediated diseases with a nucleic acid encoding AT . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Methods of Treating ATPase-mediated Diseases With a Nucleic Acid Encoding ATP1A3 and a Neuron-Specific Promoter

Information Request Form

Copyright Targeted News Service 2026